{"title":"不同诊断标准下甘油三酯血糖指数与高血压的关系","authors":"Hua Hao, Hui Geng, Mao Ma","doi":"10.2147/IJGM.S499194","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the association between triglyceride glucose index (TyG) and hypertension under different diagnostic thresholds.</p><p><strong>Methods: </strong>This study analyzed data from routine occupational health examinations conducted at the First Affiliated Hospital of Xi'an Jiaotong University in 2019. TyG and TyG-BMI, indicators of insulin resistance (IR), were calculated using triglyceride (TG), fasting blood glucose (FPG), and body mass index (BMI). Hypertension was defined by thresholds of 140/90 mmHg and 130/80 mmHg. Logistic regression models were employed to investigate the association between TyG and hypertension.</p><p><strong>Results: </strong>Among 4028 subjects, after adjusting for covariates, the risk of hypertension (diagnosed by 140/90 mmHg) was 2.87 times higher (OR=2.87, 95% CI: 2.11-3.91) in the Q4 group of TyG compared to the Q1 group. Similarly, the risk was 8.03 times higher (OR=8.03, 95% CI: 5.05-12.75) in the Q4 group of TyG-BMI than in the Q1 group. Furthermore, the risk of hypertension (diagnosed by 130/80 mmHg) was 2.93 times higher (OR=2.93, 95% CI: 2.34-3.68) in the Q4 group of TyG compared to the Q1 group, and 7.12 times higher (OR=7.12, 95% CI: 5.08-9.99) in the Q4 group of TyG-BMI than in the Q1 group. The restricted cubic spline further showed a dose-response relationship between TyG/ TyG-BMI and hypertension. In the population with a BMI of 24.0-27.9 kg/m<sup>2</sup>, the risk of developing hypertension (diagnosed by 140/90 mmHg) in the Q4 group of TyG was 2.79 times higher (OR=2.79, 95% CI: 1.67-4.66), while the Q4 group with TyG had a 3.07 times greater risk of hypertension (diagnosed by 130/80 mmHg) than the Q1 group (OR=3.07, 95% CI: 2.05-4.60).</p><p><strong>Conclusion: </strong>TyG is an independent risk factor for hypertension across different thresholds, showing a clear dose-response relationship. BMI may influence this association, emphasizing the importance of managing insulin resistance early to aid hypertension prevention.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"18 ","pages":"43-53"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720999/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association Between Triglyceride Glucose Index and Hypertension According to Different Diagnostic Criteria.\",\"authors\":\"Hua Hao, Hui Geng, Mao Ma\",\"doi\":\"10.2147/IJGM.S499194\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To explore the association between triglyceride glucose index (TyG) and hypertension under different diagnostic thresholds.</p><p><strong>Methods: </strong>This study analyzed data from routine occupational health examinations conducted at the First Affiliated Hospital of Xi'an Jiaotong University in 2019. TyG and TyG-BMI, indicators of insulin resistance (IR), were calculated using triglyceride (TG), fasting blood glucose (FPG), and body mass index (BMI). Hypertension was defined by thresholds of 140/90 mmHg and 130/80 mmHg. Logistic regression models were employed to investigate the association between TyG and hypertension.</p><p><strong>Results: </strong>Among 4028 subjects, after adjusting for covariates, the risk of hypertension (diagnosed by 140/90 mmHg) was 2.87 times higher (OR=2.87, 95% CI: 2.11-3.91) in the Q4 group of TyG compared to the Q1 group. Similarly, the risk was 8.03 times higher (OR=8.03, 95% CI: 5.05-12.75) in the Q4 group of TyG-BMI than in the Q1 group. Furthermore, the risk of hypertension (diagnosed by 130/80 mmHg) was 2.93 times higher (OR=2.93, 95% CI: 2.34-3.68) in the Q4 group of TyG compared to the Q1 group, and 7.12 times higher (OR=7.12, 95% CI: 5.08-9.99) in the Q4 group of TyG-BMI than in the Q1 group. The restricted cubic spline further showed a dose-response relationship between TyG/ TyG-BMI and hypertension. In the population with a BMI of 24.0-27.9 kg/m<sup>2</sup>, the risk of developing hypertension (diagnosed by 140/90 mmHg) in the Q4 group of TyG was 2.79 times higher (OR=2.79, 95% CI: 1.67-4.66), while the Q4 group with TyG had a 3.07 times greater risk of hypertension (diagnosed by 130/80 mmHg) than the Q1 group (OR=3.07, 95% CI: 2.05-4.60).</p><p><strong>Conclusion: </strong>TyG is an independent risk factor for hypertension across different thresholds, showing a clear dose-response relationship. BMI may influence this association, emphasizing the importance of managing insulin resistance early to aid hypertension prevention.</p>\",\"PeriodicalId\":14131,\"journal\":{\"name\":\"International Journal of General Medicine\",\"volume\":\"18 \",\"pages\":\"43-53\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-01-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720999/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of General Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/IJGM.S499194\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of General Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJGM.S499194","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Association Between Triglyceride Glucose Index and Hypertension According to Different Diagnostic Criteria.
Objective: To explore the association between triglyceride glucose index (TyG) and hypertension under different diagnostic thresholds.
Methods: This study analyzed data from routine occupational health examinations conducted at the First Affiliated Hospital of Xi'an Jiaotong University in 2019. TyG and TyG-BMI, indicators of insulin resistance (IR), were calculated using triglyceride (TG), fasting blood glucose (FPG), and body mass index (BMI). Hypertension was defined by thresholds of 140/90 mmHg and 130/80 mmHg. Logistic regression models were employed to investigate the association between TyG and hypertension.
Results: Among 4028 subjects, after adjusting for covariates, the risk of hypertension (diagnosed by 140/90 mmHg) was 2.87 times higher (OR=2.87, 95% CI: 2.11-3.91) in the Q4 group of TyG compared to the Q1 group. Similarly, the risk was 8.03 times higher (OR=8.03, 95% CI: 5.05-12.75) in the Q4 group of TyG-BMI than in the Q1 group. Furthermore, the risk of hypertension (diagnosed by 130/80 mmHg) was 2.93 times higher (OR=2.93, 95% CI: 2.34-3.68) in the Q4 group of TyG compared to the Q1 group, and 7.12 times higher (OR=7.12, 95% CI: 5.08-9.99) in the Q4 group of TyG-BMI than in the Q1 group. The restricted cubic spline further showed a dose-response relationship between TyG/ TyG-BMI and hypertension. In the population with a BMI of 24.0-27.9 kg/m2, the risk of developing hypertension (diagnosed by 140/90 mmHg) in the Q4 group of TyG was 2.79 times higher (OR=2.79, 95% CI: 1.67-4.66), while the Q4 group with TyG had a 3.07 times greater risk of hypertension (diagnosed by 130/80 mmHg) than the Q1 group (OR=3.07, 95% CI: 2.05-4.60).
Conclusion: TyG is an independent risk factor for hypertension across different thresholds, showing a clear dose-response relationship. BMI may influence this association, emphasizing the importance of managing insulin resistance early to aid hypertension prevention.
期刊介绍:
The International Journal of General Medicine is an international, peer-reviewed, open access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treatment protocols. The journal is characterized by the rapid reporting of reviews, original research and clinical studies across all disease areas.
A key focus of the journal is the elucidation of disease processes and management protocols resulting in improved outcomes for the patient. Patient perspectives such as satisfaction, quality of life, health literacy and communication and their role in developing new healthcare programs and optimizing clinical outcomes are major areas of interest for the journal.
As of 1st April 2019, the International Journal of General Medicine will no longer consider meta-analyses for publication.